Rockefeller Financial Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$35.5M Sell
189,574
-4,100
-2% -$765K 0.56% 49
2017
Q3
$32.7M Sell
193,674
-28,736
-13% -$4.35M 0.62% 46
2017
Q2
$31.9M Sell
222,410
-6,632
-3% -$891K 0.63% 41
2017
Q1
$28.7M Sell
229,042
-2,580
-1% -$299K 0.57% 45
2016
Q4
$26.1M Buy
231,622
+106
+0% +$12.3K 0.53% 47
2016
Q3
$29.8M Hold
231,516
0.62% 45
2016
Q2
$25.3M Sell
231,516
-2,600
-1% -$259K 0.51% 48
2016
Q1
$22.2M Sell
234,116
-5,719
-2% -$483K 0.43% 50
2015
Q4
$21.7M Sell
239,835
-2,907
-1% -$247K 0.42% 53
2015
Q3
$22.5M Sell
242,742
-117,366
-33% -$10.3M 0.46% 51
2015
Q2
$23.7M Sell
360,108
-1,728
-0.5% -$115K 0.49% 48
2015
Q1
$25.9M Sell
361,836
-100,078
-22% -$5.43M 0.56% 44
2014
Q4
$17.6M Buy
461,914
+5,483
+1% +$173K 0.39% 60
2014
Q3
$11.3M Buy
456,431
+18,637
+4% +$472K 0.25% 80
2014
Q2
$11M Sell
437,794
-7,613
-2% -$177K 0.25% 84
2014
Q1
$11.6M Buy
445,407
+11,070
+3% +$306K 0.25% 92
2013
Q4
$11.6M Buy
434,337
+193
+0% +$4.77K 0.25% 99
2013
Q3
$8.28M Buy
434,144
+8,446
+2% +$193K 0.19% 110
2013
Q2
$9.18M Buy
+425,698
New +$8.56M 0.22% 94

Other funds holding ABMD

Rockefeller Financial Services's ABMD Position: Q4 2017 in Review

Rockefeller Financial Services reduced its Abiomed Inc (ABMD) stake by 2.1% in Q4 2017, selling an estimated $765K and leaving 189,574 shares worth $35.5M. The position accounts for 0.56% of the portfolio, ranked #49.

Rockefeller Financial Services first reported a position in ABMD in Q2 2013 and has held it in 19 quarters since. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Rockefeller Financial Services held 189,574 shares of Abiomed Inc worth $35.5M as of Q4 2017.
  • Rockefeller Financial Services sold 4,100 Abiomed Inc shares in Q4 2017, an estimated $765K.
  • Abiomed Inc made up 0.56% of Rockefeller Financial Services's portfolio in Q4 2017, its #49 holding.
  • Rockefeller Financial Services first reported a position in Abiomed Inc in Q2 2013 and has held it in 19 quarters since.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.